A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Parkinson's Disease
Related studies linked through entity extraction aliases.
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
- Status
- TERMINATED
- Phase
- PHASE3
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- Status
- COMPLETED
- Phase
- PHASE2
STN-Stimulation Versus Best Medical Treatment in Advanced PD
- Status
- COMPLETED
- Phase
- PHASE3
Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists
- Status
- UNKNOWN
- Phase
- N/A
Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life
- Status
- UNKNOWN
- Phase
- N/A
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation
- Status
- UNKNOWN
- Phase
- NA
A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
- Status
- COMPLETED
- Phase
- PHASE4
Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies
- Status
- TERMINATED
- Phase
- N/A
Functional Characterization of Parkin + Patients
- Status
- TERMINATED
- Phase
- N/A
A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Parkin Mutations and Their Functional Consequences
- Status
- COMPLETED
- Phase
- N/A